International Journal of Cardiovascular ResearchISSN: 2324-8602

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Daniel Alejandro Lerman Author

s0978484@staffmail.ed.ac.uk 44-7854059667 | 44-785405966

Subjects of specialization
Aortic valve calcification disease, Aortic valve interstitial cells

Affiliation
Department of Cardiothoracic Surgery, Royal Infirmary Hospital of Edinburgh(NHS Lothian) The University of Edinburgh, United Kingdom

Biography

Department of Cardiothoracic Surgery, Royal Infirmary Hospital of Edinburgh(NHS Lothian) The University of Edinburgh, United Kingdom  Denosumab is a fully human monoclonal antibody and novel antiresorptive agent that works by binding receptor activator of nuclear factor kappa-β ligand (RANKL) and inhibiting the signaling cascade that causes osteoclast maturation, activity, and survival. 

Publications

Research Article Open Access

Early Results of a Novel Mitral Valve Repair Procedure: The Interpapillary Polytetrafluoroethylene Bridge Formation

Author(s):

Nasri Alotti, Károly Gombocz, Kiddy L Ume, Amer Sayour, Daniel Alejandro Lerman and Aref Rashed

Early Results of a Novel Mitral Valve Repair Procedure: The Interpapillary Polytetrafluoroethylene Bridge Formation

Objective: Background: Surgical repair of ischemic mitral regurgitation (IMR) associated with chordal rupture in patients with ischemic cardiomyopathy is challenging as it aims to correct several structural pathologies at once. There are ongoing studies evaluating multiple approaches, however long term results are still scarce.

Methods and Results: 19 patients with IMR underwent mitral valve repair with int... view more»

DOI: 10.4172/2324-8602.1000254

Abstract HTML PDF

Google Scholars / Researchers Sites

Explore SciTechnol

GET THE APP